XBiotech
XBIT
31 hedge funds and large institutions have $10.6M invested in XBiotech in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.21M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.19M |
| 3 |
FHC
Forest Hill Capital
Little Rock,
Arkansas
|
+$933K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$653K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$547K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $8K | +$9.64K | +465 | New |
|
27
Invesco
Atlanta,
Georgia
| $5K | +$5.68K | +274 | New |
|
28
Wells Fargo
San Francisco,
California
| $4K | +$4.19K | +202 | New |
|
29
Bank of America
Charlotte,
North Carolina
| $2K | +$2.3K | +111 | New |
|
30
Citigroup
New York
| $1K | +$1.12K | +54 | New |
|
31
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $19 | +$21.6K | +1,039 | New |
|
XBIT Hedge Fund Activity: Q2 2015 in Review
31 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2015, worth a combined $10.6M.
Buyers outnumbered sellers: 31 funds opened new XBIT positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $4.21M.
- 31 institutional investors held XBiotech (XBIT) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $10.6M of XBiotech stock for Q2 2015.
- 31 funds opened new XBiotech positions in Q2 2015 and 0 closed out, a net change of +31 holders.
- The largest XBiotech buyer in Q2 2015 was Vanguard Group, an estimated $4.21M added.
Based on aggregated 13F filings for Q2 2015.